Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study

Mato, A. R., Pagel, J. M., Coombs, C. C., Shah, N. N., Lamanna, N., Munir, T., Lech-Marańda, E., Eyre, T. A., Woyach, J. A., Wierda, W. G., Cheah, C. Y., Cohen, J. B., Roeker, L. E., Patel, M. R., Fakhri, B., Barve, M. A., Tam, C. S., Lewis, D. J., Gerson, J. N., … Jurczak, W. (2021). Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study. Blood, 138(Supplement 1), 391–391. https://doi.org/10.1182/blood-2021-147599
Authors:
Anthony R. Mato
John M. Pagel
Catherine C. Coombs
Nirav N. Shah
Nicole Lamanna
Tahla Munir
Ewa Lech‐Marańda
Toby A. Eyre
Jennifer A. Woyach
William G. Wierda
Chan Y. Cheah
Jonathon B. Cohen
Lindsey E. Roeker
Manish R. Patel
Bita Fakhri
Minal Barve
Constantine S. Tam
David John Lewis
James N. Gerson
Alvaro J. Alencar
Chaitra S. Ujjani
Ian W. Flinn
Suchitra Sundaram
Shuo Ma
Deepa Jagadeesh
Joanna Rhodes
Justin Taylor
Omar Abdel‐Wahab
Paolo Ghia
Stephen J. Schuster
Denise Wang
Binoj C. Nair
Edward Y. Zhu
Donald E. Tsai
Matthew S. Davids
Jennifer R. Brown
Wojciech Jurczak
Affiliated Authors:
Nicole Lamanna
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-147599
DOI:
10.1182/blood-2021-147599
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: